Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Tullius

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Surgery|April 1, 1997
Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resectionS Jonas, W O Bechstein, T Heinze, et al.
Transplantation Proceedings|June 24, 1998
Donor-recipient sex matching and posttransplant malignancies after induction therapy in hepatic transplantationS Jonas, U Neumann, O Guckelberger, et al.
Kidney International|December 16, 1998
Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the ratD Dragun, I Lukitsch, S G Tullius, et al.
Transplantation Proceedings|February 1, 1995
Influence of renal mass on chronic kidney allograft rejection in ratsU W Heemann, H Azuma, S G Tullius, et al.
Transplantation Proceedings|June 24, 1998
Development of tolerance in a chronic rejection modelS G Tullius, M Nieminen, W O Bechstein, et al.
Experimental Nephrology|March 1, 1993
Adhesion molecule interaction with extracellular matrixJ W Kupiec-Weglinski, U W Heemann, A J Coito, et al.
Transplantation|October 27, 1997
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantationJ Pratschke, R Neuhaus, S G Tullius, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: ten-year follow-upS Jonas, O Guckelberger, A R Müller, et al.
Transplantation Proceedings|November 20, 1997
Early acute rejection episodes are reversible following retransplantation into a syngeneic donor and do not progress to chronic rejectionS G Tullius, M Nieminen, W O Bechstein, et al.
Cancer|September 26, 1997
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulinS Jonas, N Rayes, U Neumann, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Surgery|April 1, 1997
Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resectionS Jonas, W O Bechstein, T Heinze, et al.
Transplantation Proceedings|June 24, 1998
Donor-recipient sex matching and posttransplant malignancies after induction therapy in hepatic transplantationS Jonas, U Neumann, O Guckelberger, et al.
Kidney International|December 16, 1998
Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the ratD Dragun, I Lukitsch, S G Tullius, et al.
Transplantation Proceedings|February 1, 1995
Influence of renal mass on chronic kidney allograft rejection in ratsU W Heemann, H Azuma, S G Tullius, et al.
Transplantation Proceedings|June 24, 1998
Development of tolerance in a chronic rejection modelS G Tullius, M Nieminen, W O Bechstein, et al.
Experimental Nephrology|March 1, 1993
Adhesion molecule interaction with extracellular matrixJ W Kupiec-Weglinski, U W Heemann, A J Coito, et al.
Transplantation|October 27, 1997
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantationJ Pratschke, R Neuhaus, S G Tullius, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: ten-year follow-upS Jonas, O Guckelberger, A R Müller, et al.
Transplantation Proceedings|November 20, 1997
Early acute rejection episodes are reversible following retransplantation into a syngeneic donor and do not progress to chronic rejectionS G Tullius, M Nieminen, W O Bechstein, et al.
Cancer|September 26, 1997
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulinS Jonas, N Rayes, U Neumann, et al.
Pageof 11